1National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases.USRDS 1997 Annual Data Report[C].Bethesda,MD,USA:National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Diseases,1997.
2Foley RN,Parfrey PS,Sarnak MJ.Epidemiology of cardiovascular disease in chronic renal disease[J].J Am Soc Nephrol,1998; 9 (Suppl.12):S16-23.
3Sarnak MJ,Levey AS,Schoolwerth AC,et al.Kidney disease as a risk factor for development of cardiovascular disease:a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease,High Blood Pressure Research,Clinical Cardiology,and Epidemiology and Prevention[J].Circulation,2003; 108 (17):2154-69.
4Al Suwaidi J,Reddan DN,Williams K,et al.Prosnostic implications of abnormalities in renal function in patients with acute coronary syndromes[J].Circulation,2002; 106 (8):974-80.
5Best PJ,Lennon R,Ting HH,et al.The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions[J].J Am Coll Cardiol,2002;39(7):1113-9.
6Gibson CM,Pinto DS,Murphy SA,et al.Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality[J].J Am Coll Cardiol,2003 ;42 (9):1535-43.
7Oh J,Wunsch R,Turzer M,et al.Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure[J].Circulation,2002; 106 (1):100-5.
9Heymes C,Bendall JK,Ratajczak P,et al.Increased myocardial NADPH oxidase activity in human heart failure[J].J Am Coll Cardiol,2003; 41(12):2164-71.
10Tojo A,Onozato ML,Kobayashi N,et al.Angiotensin Ⅱ and oxidative stress in Dahl Salt-sensitive rat with heart failure[J].Hypertension,2002; 40(6):834-9.
二级参考文献19
1郑泰山 项坤三 等.-[J].中华内分泌代谢杂志,1997,13:201-205.
2[1]Huang W, Gallois Y, Bouby N, et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci USA,2001,98 13330～13334.
3[2]Nguyen G,Delarue F,Burckle C,et al.Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.J Clin Invest,2002,109 1417～1427.
4[3]Robert M, Helmy M. The intrarenal rennin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab, 2003,14 274～281.
5[4]Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid concentrations of angiotensins I and Ⅱin anesthetized rats. Hypertension,2002,39 129～134.
6[5]Toke A, Meyer TW. Hemodynamic effects of angiotensin II in the kidney. Contrib Nephrol,2001,135 34～46.
7[6]Wolf G, Butzmann U, Wenzel U. The renin-angiotensin system and progression of renal disease: From hemodynamics to cell biology. Nephron Physiol,2003,93 3～13.
8[7]Cao Z,Kelly DJ,Cox A,et al.Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis.Kidney Int,2000,58 2437～2451.
9[8]Ling Y, Nancy A, Wayne A. Therapeutic strategies to halt renal fibrosis. Curr Opin Pharmacol, 2002, 2 177～181.
10[9]Gaedeke J, Peters H, Nobel NA, et al. Angiotension II,TGF-β and renal fibrosis. Contrib Nephrol, 2001, 135 153～160.
6Mussap M,Plebani M.Biochemistry and clinical role of human cystatin C[J].Crit Rev Clin Lab Sci,2004,41(5/6):467-550.
7Shlipak MG,Katz R,Fried LF,et al.Cystatin-C and mortality in elderly persons with heart failure[J].J Am Coll Cardiol,2005,45(2):268-271.
8Sukhova GK,Wang B,Libby P,et al.Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice[J].Circ Res,2005,96(3):368-375.
9Koenig W,Twardella D,Brenner H,et al.Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate[J].Clin Chem,2005,51(2):321-327.
10Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol,2008,52:1527-1539.
